Loading company…
Novomore Biotechnology develops plant-derived biological compounds for pharmaceutical applications.
Novomore Biotechnology develops biological compounds using plant synthetic biology for the biopharmaceutical industry. Founded in 2022 and based in Changsha, China, it closed a Series A funding round in September 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in